Literature DB >> 27518985

Hepatic degradation of insulin and the release of its component A and B chains.

D D Bansal1, J S Bajaj1, D McMaster1, J Vallance-Owen1.   

Abstract

This study confirms that insulin is degraded in the liver, that the immediate degradation products are its A and B chains, and that these are released to the circulation. The study also shows that the A and B chains when perfused for 31 minutes through the isolated rate livers were not degraded. The inference of the study is that the B chain is available for the production of synalbumin insulin antagonism.

Entities:  

Year:  1975        PMID: 27518985     DOI: 10.1007/BF02939041

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Conservation of the synalbumin insulin antagonist.

Authors:  J Vallance-Owen; D McMaster
Journal:  Clin Chim Acta       Date:  1973-04-19       Impact factor: 3.786

2.  Antagonism to insulin action on the perfused hind limb of the rat by a reduced insulin B chain-albumin complex.

Authors:  R J Mahler; O Szabo; J C Penhos
Journal:  Diabetes       Date:  1968-01       Impact factor: 9.461

3.  Hepatic production of an albumin-associated insulin inhibitor.

Authors:  N Voyles; J C Penhos; L Recant
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

4.  Insulin antagonism of normal and diabetic albumin after liver perfusion.

Authors:  J S Bajaj; J Vallance-Owen
Journal:  Lancet       Date:  1971-01-02       Impact factor: 79.321

5.  Insulin degradation. VI. Feedback control by insulin of liver glutathione-insulin transhydrogenase in rat.

Authors:  P T Varandani
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

6.  ANTAGONISM OF INSULIN ACTION ON MUSCLE BY THE ALBUMIN-BOUND B CHAIN OF INSULIN.

Authors:  J W ENSINCK; R J MAHLER; J VALLANCE-OWEN
Journal:  Biochem J       Date:  1965-01       Impact factor: 3.857

7.  The dominant role of the liver in plasma protein synthesis; a direct study of the isolated perfused rat liver with the aid of lysine-epsilon-C14.

Authors:  L L MILLER; C G BLY; M L WATSON; W F BALE
Journal:  J Exp Med       Date:  1951-11       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.